A carregar...
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...
Na minha lista:
| Publicado no: | Turk J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Galenos Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282540/ https://ncbi.nlm.nih.gov/pubmed/28182165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjo.26780 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|